Schizophrenia research

Keyphrases

Publications

volume 274, 2024

Elif Kizilay, Berat Arslan, Burcu Verim, Cemal Demirlek, Muhammed Demir, Ezgi Cesim, Merve Sumeyye Eyuboglu, Simge Uzman Ozbek, Ekin Sut, Berna Yalincetin, Emre Bora
Automated linguistic analysis in youth at clinical high risk for psychosis. Schizophrenia research 274 (2024)
F T Greenway, M Weal, E C Palmer-Cooper
Hybrid mHealth care: Patient perspectives of blended treatments for psychosis. A systematic review. Schizophrenia research 274 (2024)
Di Lisi Alessandro, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Giuseppina Paulillo, Simona Pupo, Pietro Pellegrini, Menchetti Marco, Pelizza Lorenzo
Obsessive-compulsive symptoms in individuals at clinical high risk for psychosis: A 2-year longitudinal study. Schizophrenia research 274 (2024)
Megan Snelleksz, Elizabeth Scarr, Brian Dean
Lower levels of kainate receptors, but not AMPA or NMDA receptors, in Brodmann's area (BA) 9, but not BA 10, from a subgroup of people with schizophrenia who have a marked deficit in cortical muscarinic M1 receptors. Schizophrenia research 274 (2024)
Qiao Su, Zaimina Xuekelaiti, Hongyun Ma, Yuying Qiu, Xiaoxiao Sun, Fuyou Bi, Meijuan Li, Jie Li
The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophrenia. Schizophrenia research 274 (2024)
Lorenzo Pelizza, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Simona Pupo, Giuseppina Paulillo, Pietro Pellegrini, Marco Menchetti
Rates and predictors of service disengagement in first episode psychosis: Results from a 2-year follow-up study in an Italian real-world care setting. Schizophrenia research 274 (2024)
William P Horan, Steven D Targum, Amy Claxton, Inder Kaul, Samantha E Yohn, Stephen R Marder, Andrew C Miller, Stephen K Brannan
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials. Schizophrenia research 274 (2024)
Chao Wu, Shenglin She, Bingyan Gong, Qiuhong Li, Yu Xia, Xiaohua Lu, Yi Liu, Huawang Wu, Yingjun Zheng
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia. Schizophrenia research 274 (2024)
Vijai Raj, Nicolette Stogios, Sri Mahavir Agarwal, Arthur J Cheng
The neuromuscular basis of functional impairment in schizophrenia: A scoping review. Schizophrenia research 274 (2024)
Simon Ploug Gartner, Tina Bech Olesen, Henry Jensen, Lotte Maxild Mortensen, Lone Baandrup
Recognition of schizophrenia and quality of treatment during the COVID-19 pandemic: A Danish nationwide study. Schizophrenia research 274 (2024)
Judy L Thompson, Steven M Silverstein, Thomas V Papathomas, Brian P Keane
Hallucinations and the depth-inversion illusion in schizophrenia. Schizophrenia research 274 (2024)
Mushde Shakir, Peter N van Harten, Adriaan W Hoogendoorn, Anne E Willems, Diederik E Tenback
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects. Schizophrenia research 274 (2024)
Marco Kramer, Fiona Fink, Lorenz A Campo, Erhan Akinci, Max-Oskar Wieser, Georg Juckel, Paraskevi Mavrogiorgou
Video analysis of interaction in schizophrenia reveals functionally relevant abnormalities. Schizophrenia research 274 (2024)
Peter Phalen, Nev Jones, Beshaun Davis, Deepak Sarpal, Faith Dickerson, Crystal Vatza, Megan Jumper, Adam Kuczynski, Elizabeth Thompson, Samantha Jay, Robert Buchanan, K N R Chengappa, Richard Goldberg, Julie Kreyenbuhl, Russell Margolis, Fanghong Dong, Jessie Riggs, Alex Moxam, Elizabeth Burris, Philip Campbell, Akinyi Cooke, Arielle Ered, Mandy Fauble, Carolyn Howell, Christian Kelly, Denise Namowicz, Krissa Rouse, William Smith, Max Wolcott, Yasmine Boumaiz, Alexander Harvin, R Scheinberg, Arunadevi Saravana, Swati Nayar, Christian Kohler, Monica E Calkins, Melanie Bennett
Suicidality among clients in a network of coordinated specialty care (CSC) programs for first-episode psychosis: Rates, changes in rates, and their predictors. Schizophrenia research 274 (2024)
Virginio Salvi, Beniamino Tripodi, Giancarlo Cerveri, Giovanni Migliarese, Lorenzo Bertoni, Gabriele Nibbio, Stefano Barlati, Antonio Vita, Claudio Mencacci
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review. Schizophrenia research 274 (2024)
Rebecca Lee, Sian Lowri Griffiths, Georgios V Gkoutos, Stephen J Wood, Laura Bravo-Merodio, Paris A Lalousis, Linda Everard, Peter B Jones, David Fowler, Joanne Hodegkins, Tim Amos, Nick Freemantle, Swaran P Singh, Max Birchwood, Rachel Upthegrove
Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction model. Schizophrenia research 274 (2024)
Baktash Babadi, Katherine Dokholyan, Nicole R DeTore, Roger B H Tootell, Rachel F Sussman, Sarah L Zapetis, Daphne J Holt
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study. Schizophrenia research 274 (2024)
Willa Molho, Brendan Stiltner, Nicolas Raymond, Chelsea Kiely, Rebekah Trotti, Caroline Harris, Deepthi Bannai, Matcheri Keshavan, Steven Silverstein, Paulo Lizano
Retinal electrophysiological alterations are associated with cognition in early course psychosis. Schizophrenia research 274 (2024)

volume 272, 2024

Vid Mlakar, Ibrahim Akkouh, Els F Halff, Deepak P Srivastava, Viktoria Birkenæs, Torill Ueland, Daniel S Quintana, Monica B E G Ormerod, Nils Eiel Steen, Srdjan Djurovic, Ole A Andreassen, Monica Aas
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition. Schizophrenia research 272 (2024)
Allison S Brandt, Frederick C Nucifora, Peter P Zandi, Russell L Margolis
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated? Schizophrenia research 272 (2024)
Jason Smucny, Avery Wood, Ian N Davidson, Cameron S Carter
Are factors that predict conversion to psychosis associated with initial transition to a high risk state? An adolescent brain cognitive development study analysis. Schizophrenia research 272 (2024)
M Berkhof, E C D van der Stouwe, C N W Geraets, R M C A Pot-Kolder, M van der Gaag, W Veling
Relations between changes in safety behavior, paranoid ideations, cognitive biases, and clinical characteristics of patients with a psychotic disorder over time. Schizophrenia research 272 (2024)
Sorcha J Cotter, Catherine L Smith, Caroline X Gao, Rahul Khanna, Brian O'Donoghue, Ellie Brown, Andrew Thompson
What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services? Schizophrenia research 272 (2024)
Helio Elkis, Debora Luciana Melzer-Ribeiro, Isabel Cristina Napolitano
Response to Markota et al. "Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia" SCHRES-D-24-00481. Schizophrenia research 272 (2024)
Seo Ho Song, Tuna Cem Hayirli, Oliver Shore, Cristinel Coconcea, Matcheri Keshavan
Atypical presentation of schizophrenia with ablution avoidance: A case report. Schizophrenia research 272 (2024)
Mina Shirinbakhshmasoleh, Laila Aboulatta, Christine Leong, Hayley Riel, Kun Liu, Joseph C Delaney, James M Bolton, Jamison Falk, Silvia Alessi-Severini, Sherif Eltonsy, Kaarina Kowalec
The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba - A population-based study. Schizophrenia research 272 (2024)
Eric A Reavis, Jonathan K Wynn, Michael F Green
Pre-stimulus EEG phase coherence predicts visual target detection failures in schizophrenia: A pilot study. Schizophrenia research 272 (2024)
Matej Markota, Paul E Croarkin, Brandon J Coombes, Melanie T Gentry, Jonathan G Leung
Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia. Schizophrenia research 272 (2024)
Steven D Targum, Tingting Ge, Mahnaz Asgharnejad, Petra Reksoprodjo, Jaskaran B Singh, Venkatesha Murthy
Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms. Schizophrenia research 272 (2024)
Mona Redlich Bossy, Daniel R Müller, Mounira Jabat, Achim Burrer, Tobias R Spiller, Stefan Vetter, Erich Seifritz, Stephan T Egger
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis. Schizophrenia research 272 (2024)
Zhengshan Liu, Yu H Sun, Yue Ren, Jessica Marie Perez, Daniel Scott, Carol Tamminga
Upregulated solute-carrier family genes in the hippocampus of schizophrenia can be rescued by antipsychotic medications. Schizophrenia research 272 (2024)
Bryan Gu, Jennifer Rose, Matthew M Kurtz
Cognitive training for schizophrenia: Do race and ethnicity matter? Schizophrenia research 272 (2024)
Francois R Foerster, E Joos, B Martin, J T Coull, A Giersch
Self and time in individuals with schizophrenia: A motor component? Schizophrenia research 272 (2024)
Desmond J Spann, David C Cicero, Kelsey T Straub, Amelia M Pellegrini, John G Kerns
Examining measures of schizotypy for gender and racial bias using item response theory and differential item functioning. Schizophrenia research 272 (2024)
Amy M Jimenez, Michael F Green
Disturbance at the self-other boundary in schizophrenia: Linking phenomenology to clinical neuroscience. Schizophrenia research 272 (2024)
Michele Poletti, Andrea Raballo
Ontogenesis of self-disorders in the schizophrenia spectrum: A phenomenological neuro-developmental model. Schizophrenia research 272 (2024)
Marc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, Berna B K Akdede, A Elif Anıl Yağcıoğlu, Thomas R E Barnes, Britta Galling, Ralitza Gueorguieva, Siegfried Kasper, Anatoly Kreinin, Jimmi Nielsen, René Ernst Nielsen, Gary Remington, Eila Repo-Tiihonen, Christian Schmidt-Kraepelin, Saeed S Shafti, Le Xiao, Christoph U Correll, Robbert-Jan Verkes
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data. Schizophrenia research 272 (2024)

volume 271, 2024

Shaun M Eack
Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia. Schizophrenia research 271 (2024)
Cintia R Prokopez, Juan I Cesarini, Ricardo M Corral, Lucía Seré, Nahuel Chambeaud Helguera, Martín Alomo
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey. Schizophrenia research 271 (2024)
Yushi W MacMillan-Wang, Jennifer M Hensel, Christine Leong, Rajat Jayas, Eunice Valencia, Arianna Yorski, Kun Liu
Evaluating the impact of COVID-19 on medication adherence and health care utilization among individuals with psychotic disorders who are prescribed long-acting injectables (LAIs) or clozapine: A population-based study in Manitoba, Canada. Schizophrenia research 271 (2024)
Cheng C Chen, Joshua Howie, Mahbod Ebrahimi, Kowsar Teymouri, Julia J Woo, Arun K Tiwari, Clement C Zai, James L Kennedy
Analysis of the complement component C4 gene with schizophrenia subphenotypes. Schizophrenia research 271 (2024)
Ana Teresa Caliman-Fontes, Flávia Vieira, Gustavo C Leal, Beatriz A Carneiro, Yana Quarantini-Alvim, Taiane V Andrade, Rodrigo P Mello, Ary Gadelha, Acioly L T Lacerda, Lucas C Quarantini
Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence. Schizophrenia research 271 (2024)
Angelina Van Dyne, Tsung-Chin Wu, David H Adamowicz, Ellen E Lee, Xin M Tu, Lisa T Eyler
Longitudinal relationships between BMI and hs-CRP among people with schizophrenia. Schizophrenia research 271 (2024)
L Kennedy, B S Ku, J Addington, C M Amir, C E Bearden, T D Cannon, R Carrión, B Cornblatt, M Keshavan, D Perkins, D Mathalon, W Stone, E Walker, S Woods, K S Cadenhead
Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts. Schizophrenia research 271 (2024)
Yujue Wang, Lijun Ouyang, Lejia Fan, Wenxiao Zheng, Zongchang Li, Jinsong Tang, Liu Yuan, Chunwang Li, Ke Jin, Weiqing Liu, Xiaogang Chen, Ying He, Xiaoqian Ma
Functional and structural abnormalities of thalamus in individuals at early stage of schizophrenia. Schizophrenia research 271 (2024)
Roxanne Sicotte, Giuseppe D'Andrea, Alexandre Dumais, Anne G Crocker, Marie Villeneuve, Edouard Brochu, Amal Abdel-Baki
Aggressive behaviors in first-episode psychosis: Distinction between the premorbid phase and the onset of psychosis. Schizophrenia research 271 (2024)
Tatsuro Asai, Tempei Ikegame, Yoshihiro Satomura, Eureka Kumagai, Takuto Minami, Susumu Morita, Masahiro Kiyota, Eimu Shoji, Zhilei Zhao, Akiko Kanehara, Mariko Tada, Naohiro Okada, Shinsuke Koike, Miki Bundo, Kazuya Iwamoto, Kiyoto Kasai, Seiichiro Jinde
Lower plasma betaine levels in men at clinical high risk for psychosis: Findings from a metabolomics investigation. Schizophrenia research 271 (2024)
Rebecca L Stephens, Isabel Leavitt, Emil Cornea, L Fredrik Jarskog, John H Gilmore
Early cognitive development and psychopathology in children at familial high risk for schizophrenia. Schizophrenia research 271 (2024)
Eleonora Maggioni, Chiara Colli, Cristina Bizzotto, Sara Finaurini, Corrado Fagnani, Emanuela Medda, Carolina Bonivento, Eleonora Rosi, Maddalena Mauri, Maria Nobile, Paolo Brambilla
Investigating the impact of L1 retrotransposons on behavior: A pilot study on young twins. Schizophrenia research 271 (2024)
Aude Salvadé, Philippe Golay, Lilith Abrahamyan, Vincent Bonnarel, Alessandra Solida, Luis Alameda, Julie Ramain, Philippe Conus
Gender differences in first episode psychosis: Some arguments to develop gender specific treatment strategies. Schizophrenia research 271 (2024)